2020 Speakers

 

 

Bernadette Abela-Ridder, Team leader, Neglected Zoonotic Diseases, World Health Organization, United States

Bernadette Abela-Ridder | Team leader, Neglected Zoonotic Diseases | World Health Organization » speaking at Vaccine Europe

Dr Tedros Adhanom Ghebreyesus, Director-General, World Health Organisation

Dr Tedros Adhanom Ghebreyesus | Director-General | World Health Organisation » speaking at Vaccine Europe

Professor Jeffrey Almond, Former Vice President Discovery Research And Development, Sanofi And Visiting Professor, University of Oxford - Oxford Vaccine Group

Professor Jeffrey Almond | Former Vice President Discovery Research And Development, Sanofi And Visiting Professor | University of Oxford - Oxford Vaccine Group » speaking at Vaccine Europe

Mohammed Alquwaizani, Executive Director of Drug Risk Assessment, SFDA, Saudi Arabia

Mohammed Alquwaizani | Executive Director of Drug Risk Assessment | SFDA » speaking at Vaccine Europe

Dr Annaliesa Anderson, Chief Scientific Officer, Bacterial Vaccines And The Hospital Business Unit, Pfizer, Pfizer

Dr Annaliesa Anderson | Chief Scientific Officer, Bacterial Vaccines And The Hospital Business Unit, Pfizer | Pfizer » speaking at Vaccine Europe

Dr Jean-Christophe Audonnet, Senior Director, International R&D Governance, Coordinator Of Zapi Imi Project, Merial, France

Dr Jean-Christophe Audonnet | Senior Director, International R&D Governance, Coordinator Of Zapi Imi Project | Merial » speaking at Vaccine Europe

Dr Roy Baynes, Senior Vice President And Head Global Clinical Development, Chief Medical Officer, Merck Research Laboratories

Dr Roy Baynes | Senior Vice President And Head Global Clinical Development, Chief Medical Officer | Merck Research Laboratories » speaking at Vaccine Europe

Sandra Blome, Senior Scientist, Friedrich-Loeffler-Institut, Germany

Prof Marc Bonten, Professor, UMC Utrecht, Netherlands

Ed Buurman, Alliance Director, CARB-X

Ed Buurman | Alliance Director | CARB-X » speaking at Vaccine Europe

Dr Miles Carroll, Dd, Public Health England, United Kingdom

Dr Danilo Casimiro, Vice President And Head, External Randd And Vaccine Platforms, Sanofi Pasteur, United States

Dr Cristina Cassetti, Branch Chief Virology Branch Division Of Microbiology And Infectious Diseases, National Institutes of Health (NIH)

Dr Cristina Cassetti | Branch Chief Virology Branch Division Of Microbiology And Infectious Diseases | National Institutes of Health (NIH) » speaking at Vaccine Europe

Dr Marco Cavaleri, Head of Office, Anti-infective and Vaccines in the Human, Medicines Evaluation Division, EMA

Dr Marco Cavaleri | Head of Office, Anti-infective and Vaccines in the Human, Medicines Evaluation Division | EMA » speaking at Vaccine Europe

Ajoy Chakrabarti, Portfolio And Platform Lead, The Bill & Melinda Gates Foundation, United States

Professor Klaus Cichutek, Vice President, Paul Ehrlich Institute

Professor Klaus Cichutek | Vice President | Paul Ehrlich Institute » speaking at Vaccine Europe

Dr Ralf Clemens, Senior Vice President, Grid Rio, Germany

Dr Ralf Clemens | Senior Vice President | Grid Rio » speaking at Vaccine Europe

Dr Isabel De La Mata, Principal Advisor For Health And Crisis Management, European Commission

Dr Isabel De La Mata | Principal Advisor For Health And Crisis Management | European Commission » speaking at Vaccine Europe

Dr Michel De Wilde, Former Senior Vice President R&D Of Sanofi Pasteur & Owner, MDW Consultant LLC

Dr Michel De Wilde | Former Senior Vice President R&D Of Sanofi Pasteur & Owner | MDW Consultant LLC » speaking at Vaccine Europe

Noemi Garcia Del Blanco, Head Of Veterinary Biologicals And Emerging Therapies, European Medicines Agency

Noemi Garcia Del Blanco | Head Of Veterinary Biologicals And Emerging Therapies | European Medicines Agency » speaking at Vaccine Europe

Dr Oliver Dibben, Senior Scientist, Virology, AstraZeneca

Dr Oliver Dibben | Senior Scientist, Virology | AstraZeneca » speaking at Vaccine Europe

Marc Dreiner, Vice President Commercial Development Global Vaccines, Pfizer

Marc Dreiner | Vice President Commercial Development Global Vaccines | Pfizer » speaking at Vaccine Europe

Richard Ducatelle, Head of the Laboratory of Veterinary Pathology, Gent University, Belgium

Richard Ducatelle | Head of the Laboratory of Veterinary Pathology | Gent University » speaking at Vaccine Europe

Cynthia Dukes, VP, Drug Development Services and Global Head of Vaccine Center of Excellence, ICON Clinical Research, United States

Elisabeth Erlacher Vindel, Head of the Antimicrobial Resistance and Veterinary Products Department, World Organisation for Animal Health, France

Elisabeth Erlacher Vindel | Head of the Antimicrobial Resistance and Veterinary Products Department | World Organisation for Animal Health » speaking at Vaccine Europe

Dr Ali Fattom, Senior Vice President Of Vaccines Research And Development, BlueWillow Biologics

Dr Ali Fattom | Senior Vice President Of Vaccines Research And Development | BlueWillow Biologics » speaking at Vaccine Europe

Bin Feng, Senior Director, Head Of Advanced Analytics And Experimental Medicine Unit, GSK, United States

Bin Feng | Senior Director, Head Of Advanced Analytics And Experimental Medicine Unit | GSK » speaking at Vaccine Europe

Caitriona Fenton, One Health Operations Senior Manager, Zoetis, Ireland

Caitriona Fenton | One Health Operations Senior Manager | Zoetis » speaking at Vaccine Europe

Dr Jorge Pinto Ferreira, Deputy Head of Department, World Organisation for Animal Health

Dr Jorge Pinto Ferreira | Deputy Head of Department | World Organisation for Animal Health » speaking at Vaccine Europe

Mr Anthony Fiore, CDC, Centers for Disease Control and Prevention

Mr Anthony Fiore | CDC | Centers for Disease Control and Prevention » speaking at Vaccine Europe

Ms Mariola Fotin-Mleczek, Chief Technology Officer, CureVac

Ms Mariola Fotin-Mleczek | Chief Technology Officer | CureVac » speaking at Vaccine Europe

Agnete Fredriksen, President And Chief Scientific Officer, Vaccibody AS, Norway

Leonard Friedland, Vice President, Scientific Affairs And Public Health Vaccines, North America, GSK, United States

Gustav Gaudernack, Chief Scientific Officer, Ultimovacs, Norway

Gustav Gaudernack | Chief Scientific Officer | Ultimovacs » speaking at Vaccine Europe

Cyril Gay, Senior National Program Leader, A.R.S. National Programs, United States

Sarah Gilbert, Professor Of Vaccinology, University of Oxford, United Kingdom

Mr Steven Gong, Vice President, Business Development & Strategy, Clover Biopharmaceuticals

Mr Steven Gong | Vice President, Business Development & Strategy | Clover Biopharmaceuticals » speaking at Vaccine Europe

Dr Simon Graham, Group Leader, Prrs Immunology, The Pirbright Institute

Dr Simon Graham | Group Leader, Prrs Immunology | The Pirbright Institute » speaking at Vaccine Europe

Dr Beth Ann Griswold-Coller, Executive Director, Vaccines Clinical Research,, Merck Research Laboratories, United States

Dr Marion Gruber, Director Of Office For Vaccines, FDA

Dr Marion Gruber | Director Of Office For Vaccines | FDA » speaking at Vaccine Europe

Dr Farshad Guirakhoo, CSO, Covaxx

Dr Farshad Guirakhoo | CSO | Covaxx » speaking at Vaccine Europe

Professor Carlos Guzman, Head Of The Department Of Vaccinology And Applied Microbiology, Helmholtz Centre for Infection Research (HZI), Germany

Dr Bart Haagmans, Working Group Leader, Department of Viroscience and Co-coordinator at ZAPI, Erasmus M.C., Netherlands

Mr Eric Halioua, President And Chief Executive Officer, PDC*line pharma SA

Mr Eric Halioua | President And Chief Executive Officer | PDC*line pharma SA » speaking at Vaccine Europe

Dr Bassam Hallis, Head Of Pre Clinical Development And General Project Manager, Public Health England, United Kingdom

Dr Bassam Hallis | Head Of Pre Clinical Development And General Project Manager | Public Health England » speaking at Vaccine Europe

Ahd Hamidi, Project Director, Batavia Biosciences, Netherlands

Ms Ana Maria Henao Restrepo, Implementation Research And Economic Analysis, Initiative For Vaccine Research, World Health Organisation

Ms Ana Maria Henao Restrepo | Implementation Research And Economic Analysis, Initiative For Vaccine Research | World Health Organisation » speaking at Vaccine Europe

Dr Jenny Hendriks, Head Biomarkers, Janssen Vaccines & Prevention B.V., Netherlands

Zahra Jawad, Group Leader Discovery Technology, Agenus, United Kingdom

Dr Karin Jooss, CSO, Gritstone Oncology, United States

Professor Gregers Jungersen, Professor Of Veterinary Immunology And Vaccinology, Technical University of Denmark, Denmark

Ms Lana Kandalaft, Director, Center Of Experimental Therapeutics, University of Lausanne

Ms Lana Kandalaft | Director, Center Of Experimental Therapeutics | University of Lausanne » speaking at Vaccine Europe

Theo Kanellos, Director Of Business Development and Alliances, Zoetis, France

Mr Thomas Kassberg, Chief Business Officer And Executive Vice President, Ultragenyx Pharmaceutical

Mr Thomas Kassberg | Chief Business Officer And Executive Vice President | Ultragenyx Pharmaceutical » speaking at Vaccine Europe

Mr Andreas Katopodis, Chief Executive Officer, Anaveon

Hans S Keirstead, Chief Executive Officer, AIVITA Biomedical, Inc., United States

Naif Khalaf Alharbi, Associate Research Scientist, Infectious Disease Research Department, Head, Quality Management Department; Head, Safety Office,, King Abdullah International Medical Research Cente, Saudi Arabia

Naif Khalaf Alharbi | Associate Research Scientist, Infectious Disease Research Department, Head, Quality Management Department; Head, Safety Office, | King Abdullah International Medical Research Cente » speaking at Vaccine Europe

Dr Samir N. Khleif, Director of the Loop Immuno-Oncology Laboratory & Professor in Medicine and Oncology, Georgetown University Medical School

Dr Jerome Kim, General Director, International Vaccine Institute

Dr Jerome Kim | General Director | International Vaccine Institute » speaking at Vaccine Europe

Joseph Kim, Chief Executive Officer, Inovio Pharmaceuticals, United States

Dr Wayne Koff, President And Chief Executive Officer, The Human Vaccines Project

Dr Wayne Koff | President And Chief Executive Officer | The Human Vaccines Project » speaking at Vaccine Europe

Dr Alexander Kort, Senior Vice President Corporate Development, Themis Bioscience, Austria

Professor Jeroen Kortekaas, Senior Scientist Virology, Wageningen University, Netherlands

Timothy Korwan, Director, New Product Development, Avantor, United States

Timothy Korwan | Director, New Product Development | Avantor » speaking at Vaccine Europe

Mr Kostas Kosmatopoulos, Chief Executive Officer, Vaxon Biotech

Mr Kostas Kosmatopoulos | Chief Executive Officer | Vaxon Biotech » speaking at Vaccine Europe

Dr Lorena Lerner, Vice President, Molecular Biology and Virology, Oncorus

Ms Angelica Loskog, Chief Executive Officer, Lokon Pharma

Ms Angelica Loskog | Chief Executive Officer | Lokon Pharma » speaking at Vaccine Europe

Dr Anthony Simon Lynch, Senior Scientific Director, Janssen R&D, Netherlands

Geoffrey Lynn, Chief Executive Officer and Co-Founder, Avidea Technologies

Geoffrey Lynn | Chief Executive Officer and Co-Founder | Avidea Technologies » speaking at Vaccine Europe

Dr Nicolas Mach, Chief Scientific Officer, MaxiVax

Dr Nicolas Mach | Chief Scientific Officer | MaxiVax » speaking at Vaccine Europe

Ariane Mccabe, Director, Global Health And Public Affairs, GlaxoSmithKline, Switzerland

Ariane Mccabe | Director, Global Health And Public Affairs | GlaxoSmithKline » speaking at Vaccine Europe

Dr Anne Moscona, Professor of Pediatrics, Physiology & Cellular Biophysics and Microbiology & Immunology, Columbia University

Dr Anne Moscona | Professor of Pediatrics, Physiology & Cellular Biophysics and Microbiology & Immunology | Columbia University » speaking at Vaccine Europe

Mr Geert Mudde, Founder and Chief Scientific Officer, Tyg Oncology Ltd

Imraan Munshi, Executive Director And Global Communications Lead For Vaccines, MSD, United States

Louis Nel, Executive Director, Global Alliance for Rabies Control, United States

Louis Nel | Executive Director | Global Alliance for Rabies Control » speaking at Vaccine Europe

Dr Martina Ochs, Global Project Head, Sanofi Pasteur

Dr Martina Ochs | Global Project Head | Sanofi Pasteur » speaking at Vaccine Europe

Prof Ab Osterhaus, Director, Research Center For Emerging Infections And Zoonoses (Riz), University of Veterinary Medicine Hannover, Netherlands

Sari Pesonen, Head Of R&D, Co-Founder, Valo Therapeutics, Finland

Dr Nikolai Petrovsky, Chairman, Vaxine Pty., Australia

Mr Sanjay Phogat, Vice President R&D, Head Dpu, Italy, GSK

Mr Sanjay Phogat | Vice President R&D, Head Dpu, Italy | GSK » speaking at Vaccine Europe

Amy Pisani, Executive Director, Vaccinate Your Family, United States

Dr Jan Poolman, Head Bacterial Vaccine Discovery And Early Development, Janssen, Netherlands

Fatema H Rafiqi, Research Programme Manager, Access to Medicine Foundation, Netherlands

Andriy Rozstalnyy, Animal Production And Health Officer, F.A.O, Italy

Andriy Rozstalnyy | Animal Production And Health Officer | F.A.O » speaking at Vaccine Europe

Mr Anguraj Sadanandam, Team Leader, Institute of Cancer Research

Mr Anguraj Sadanandam | Team Leader | Institute of Cancer Research » speaking at Vaccine Europe

Prof José Manuel Sánchez-Vizcaíno, Professor of Animal Health, Universidad Complutense de Madrid

Prof José Manuel Sánchez-Vizcaíno | Professor of Animal Health | Universidad Complutense de Madrid » speaking at Vaccine Europe

Dr Hanneke Schuitemaker, Vice President And Head Of Viral Vaccine Discovery And Translational Medicine, Janssen, Netherlands

William Smith, Chief Executive Officer, Alliance for Multispecialty Research LLC, United States

Ms Julia Spencer, Associate Vice President, Global Vaccine Public Policy, Partnerships, MSD

Ms Julia Spencer | Associate Vice President, Global Vaccine Public Policy, Partnerships | MSD » speaking at Vaccine Europe

Terrence Stull, SVP Research, Phoenix Childrens Hospital, United States

Terrence Stull | SVP Research | Phoenix Childrens Hospital » speaking at Vaccine Europe

Dr Nigel Swift, Global Head of Veterinary Public Health, Boehringer Ingelheim

Dr Nigel Swift | Global Head of Veterinary Public Health | Boehringer Ingelheim » speaking at Vaccine Europe

Carolina Tafalla, Head Researcher, I.N.I.A., Spain

Carolina Tafalla | Head Researcher | I.N.I.A. » speaking at Vaccine Europe

Nicola Ternette, Head of Immunopeptidomics, University of Oxford

Nicola Ternette | Head of Immunopeptidomics | University of Oxford » speaking at Vaccine Europe

Jeroen van Bergen, CSO, Immunetune BV, Netherlands

Jeroen van Bergen | CSO | Immunetune BV » speaking at Vaccine Europe

Dr Joris Vandeputte, President, IABS, Belgium

Thomas Verstraeten, Managing Director P95, P95, Belgium

George Warimwe, Associate Professor of Vaccinology, University of Oxford, United Kingdom

George Warimwe | Associate Professor of Vaccinology | University of Oxford » speaking at Vaccine Europe

Professor Mark Wilcox, Professor Of Medical Microbiology And Deputy-Chair, Aprhai, University of Leeds, United Kingdom

Todd Wolynn, Chief Executive Officer And President, Kids Plus Pediatrics, United States

Todd Wolynn | Chief Executive Officer And President | Kids Plus Pediatrics » speaking at Vaccine Europe

Mr Tal Zaks, Chief Medical Officer, Moderna Therapeutics

Mr Tal Zaks | Chief Medical Officer | Moderna Therapeutics » speaking at Vaccine Europe